Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
fda
life sciences
national
national blog main
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drug prices
health
indiana blog main
indiana top stories
loxo oncology
new york blog main
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
tc
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acquisition
adaptimmune
allergan
allogeneic
alnylam
What
home
5
×
annual
clinical
days
drug
fda
new
patients
therapy
today
ahead
airport
alto
ambien
american
announced
apocalypse
app
approved
asco
atrophy
attendees
attention
based
beds
biofourmis
biotech
boston
breakthrough
camp’s
cancer
cash
celgene
cerebral
chicago
city
closer
combinations
community’s
company
Language
unset
Current search:
home
×
biotech
×
@techcrunch.com
2 years ago
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
@techcrunch.com
2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More